SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF (SCHD) is gaining significant attention and showing strong resilience, often posting gains even as broader markets experience downturns, cementing its perception as a "flight to safety" asset. The community is actively discussing its consistent dividend growth and potential benefits from sector rotation away from tech, though some investors anticipate a pullback due to an extended valuation.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is trending as it announced its first commercial ZEVASKYN patient treatment and secured a permanent J-code for smoother reimbursement, reinforcing its projected path to profitability in the first half of 2026. The community highlights the stock's deep undervaluation against its cash position and immense revenue potential, fueling speculation of a re-rating as patient treatments for the rare disease gene therapy ramp up.

WorldFinancial

WLFI is actively discussed due to a US House probe into its $500 million investment deal with an Abu Dhabi-affiliated entity, sparking conflict-of-interest concerns, while supporters point to its USD1 stablecoin's increasing market cap, a significant Binance integration, and anticipated Real World Asset (RWA) platform. The community remains divided between those who see it as a legitimate project tied to the Trump family's vision for decentralized finance and those who label it a pump-and-dump scheme.

Lowe's Companies, Inc. engages in the retail sale of home improvement products. The firm offers products for maintenance, repair, remodeling, home decorating, and property maintenance. It also provides home improvement products in the following categories: appliances, seasonal & outdoor living, lumber, lawn & garden, kitchens & bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrical, flooring, and décor. The company was founded in 1946 and is headquartered in Mooresville, NC.

Lowe`s Cos., Inc.

Lowe's Companies, Inc.

Lowe's is seeing increased conversation after its Q4 earnings outperformed expectations, fueled by a return to positive comparable sales and robust Pro segment growth, which offsets persistent DIY and housing market pressures. The company's strategic acquisition of Foundation Building Materials and cautious guidance for the upcoming year are leading to community debate about its resilience and competitive positioning against Home Depot.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and decor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending following a downward revision to its full-year outlook after missing Q3 earnings, citing soft big-ticket demand and macroeconomic headwinds, which is intensifying community debate around its short-term trajectory despite ongoing strategic investments in its Pro ecosystem and digital initiatives.

SSgA Active Trust - State Street Industrial Select Sector SPDR ETF

Industrial Select Sector SPDR Fund

XLI is trending, hitting new highs as market participants rotate into industrials, bolstered by strong manufacturing data and robust earnings forecasts, with community discussion highlighting an "American Industrial Revival" and continued technical strength.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending following positive Q4 earnings that beat expectations and the announcement of a strategic collaboration with SDCL for up to 450 MW of fuel cell power for AI data centers. The community is actively discussing FCEL's potential to capitalize on the immense demand for on-site energy solutions in the rapidly expanding AI sector, drawing comparisons to competitors' successful data center initiatives.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC is a focal point of investor debate after its challenging earnings report and substantial dividend cut sparked widespread concern over the agricultural sciences company's financial health and leadership, though a segment of the community sees the stock as deeply oversold with potential for a rebound or strategic acquisition.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health Inc. is trending due to its reaffirmed FY25 outlook and strong VEVYE script growth, which is significantly boosted by recent CVS Caremark Tier 1 formulary status. This has ignited community discussion about the company's substantial long-term potential and the likelihood of a short squeeze, with many investors actively calling it undervalued.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending following a recent regulatory filing signaling a potential Berkshire Hathaway stake sale, which has sparked intense community debate while reinforcing its position as a defensive "cash cow" with strong earnings, a substantial share buyback program, and an appealing dividend yield amid market rotation to safety. Investors are discussing the company's intrinsic value and potential for further upside from an anticipated stock split.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ginkgo Bioworks (NYSE:DNA) Trading Up 19.3% - Here's What Happened

Ginkgo Bioworks (NYSE:DNA) Trading 19.3% Higher - Time to Buy...

Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark

Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5...

Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today

In the closing of the recent trading day, Ginkgo Bioworks Holdings, Inc. (DNA) stood at $8.27, denoting a -5.92% move from the preceding trading day.

Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors

Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $9.31, signifying a -1.27% move from its prior day's close.

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note

In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $10.02, marking a -6.36% move from the previous day.

Ginkgo Bioworks (NYSE:DNA) Stock Price Up 12.2% - Here's What Happened

Ginkgo Bioworks (NYSE:DNA) Trading 12.2% Higher - Still a Buy...

Ginkgo Bioworks (NYSE:DNA) Trading Down 8.8% - Time to Sell?

Ginkgo Bioworks (NYSE:DNA) Shares Down 8.8% - Here's Why...

Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know

In the most recent trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.85, indicating a +2.39% shift from the previous trading day.

Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference PR Newswire...

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts

In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.06, marking a -5.72% move from the previous day.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$9.95
Prev Close	$8.32
Open	$8.93
Dividend Yield	0.00%
50-Day Moving Average	$9.10
Beta	2.56
Avg. Volume	850,194.85
PE Ratio	-1.62

52-Week High	$17.58
52-Week Low	$5.00
Market Capitalization	$611.96M
EPS (Annual)	-$10.54
Price to Book	0.97
Revenue Per Employee	$272,233.81
Enterprise Value/EBITDA	N/A

DNA
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DNA News

DNAGinkgo Bioworks Holdings Inc - Ordinary Shares - Class A